Skip to main content
. 2015 Nov 12;6(11):e124. doi: 10.1038/ctg.2015.46

Figure 1.

Figure 1

Schematic for evaluating Mendelian and complex disorders. Genetic testing for Mendelian disorders is a well-established discipline with the ultimate goal of identifying, confirming, or ruling out a highly penetrant genetic disorder. In complex disorders, genetic information using single-nucleotide polymorphism (SNP) arrays or next generation sequencing (NGS) panels are combined with other risk factors and markers within a disease model to classify patients based on disease mechanism. The actionable result(s) lead to better management of the patient based on targeted therapies and avoiding adverse outcomes.